X
X
Top

India's Hetero Labs bags approval to sell Coronavirus drug favipiravir

Indias Hetero Labs bags approval to sell Coronavirus drug favipiravir
x

Coronavirus anti-viral drug favipiravir

Highlights

Another Indian company has received regulatory approval to sell its version of anti-viral drug favipiravir to treat coronavirus.

India's Hetero wins approval to sell Covid-19 drug favipiravir. Another Indian company has received regulatory approval to sell its version of anti-viral drug favipiravir to treat coronavirus.

The drugmaker made the announcement on Wednesday as coronavirus infections in the world's third worst-hit nation crossed 1.5 million. The drug, priced at Rs 59 per tablet, has been approved to treat mild to moderate Covid-19 cases and will be available at drug stores from Wednesday, said privately held Hetero in a statement.

Show Full Article
Print Article
Download The Hans India Android App or iOS App for the Latest update on your phone.
Subscribed Failed...
Subscribed Successfully...
Next Story
More Stories